BMRN
BioMarin Pharmaceutical Inc. (BMRN)
Last Price$70.5(2.1%)
Market Cap$13.4B
LTM Return on Invested Capital (ROIC)
11.0%
5Y avg
8.5%
Biotechnology industry median
(139.1%)
Stock quality & Intrinsic value
7/10
(0.3%) overvalued

BioMarin Pharmaceutical Inc. Return on Invested Capital (ROIC)

Annual
Quarterly
LTM
Industry median
Company stand-alone
BMRN
Healthcare
Crunching data... Almost there!
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Return on Invested Capital (ROIC)
(68.0%)
(40.1%)
(41.2%)
19.6%
4.8%
45.8%
(6.7%)
(15.1%)
(22.4%)
(11.4%)
(8.8%)
(32.0%)
(4.7%)
(2.6%)
(2.3%)
31.7%
(1.9%)
1.9%
6.0%
12.0%
BMRN
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for BMRN and see if it's the right time to invest.
Dive in

BioMarin Pharmaceutical Inc. (BMRN) Return on Invested Capital (ROIC) comparison analysis

BMRN key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
% growth
25.7
37.7%
84.2
228.1%
121.6
44.4%
296.5
143.9%
324.7
9.5%
376.3
15.9%
441.4
17.3%
500.7
13.5%
548.5
9.5%
751.0
36.9%
889.9
18.5%
1,116.9
25.5%
1,313.6
17.6%
1,491.2
13.5%
1,704.0
14.3%
1,860.5
9.2%
1,846.3
(0.8%)
2,096.0
13.5%
2,419.2
15.4%
2,853.9
18.0%
Cost of Goods Sold (COGS)2.68.718.452.565.970.384.091.895.7129.8152.0209.6241.8315.3359.5524.3470.5483.7577.1580.2
% margin
23.0
89.8%
75.5
89.6%
103.2
84.9%
244.0
82.3%
258.7
79.7%
306.0
81.3%
357.3
81.0%
408.9
81.7%
452.7
82.5%
621.3
82.7%
737.9
82.9%
907.2
81.2%
1,071.9
81.6%
1,175.9
78.9%
1,344.6
78.9%
1,336.2
71.8%
1,375.8
74.5%
1,612.4
76.9%
1,842.2
76.1%
2,273.7
79.7%
Operating Expenses87.3100.1160.5204.2242.3299.0389.8519.1608.8781.71,019.41,111.51,211.61,349.51,470.01,432.41,458.11,570.81,746.31,789.5
Research & Development Expenses (R&D)56.466.778.693.3115.1147.3214.4302.2354.8461.5634.8661.9610.8696.3715.0628.1628.8649.6746.8747.2
Selling, General & Administrative Expenses (SG&A)41.649.077.5106.6124.3151.7175.4198.2235.4302.2402.3476.6554.3604.4680.9737.7759.4854.0937.31,009.0
(64.2)
(250.2%)
(24.7)
(29.3%)
(57.3)
(47.1%)
39.8
13.4%
16.4
5.1%
0.5
0.1%
(33.9)
(7.7%)
(110.2)
(22.0%)
(156.0)
(28.4%)
(92.9)
(12.4%)
(110.7)
(12.4%)
(803.4)
(71.9%)
(14.7)
(1.1%)
(123.5)
(8.3%)
(125.5)
(7.4%)
(96.3)
(5.2%)
(60.0)
(3.3%)
57.5
2.7%
194.4
8.0%
484.2
17.0%
Interest Income1.912.90.016.45.14.12.92.63.15.94.57.514.922.822.716.610.518.058.374.9
Interest Expense11.916.70.016.414.110.38.37.610.436.638.239.542.743.723.529.315.316.017.312.3
Pre-tax Income(74.3)(28.5)(15.1)33.40.6(21.5)(43.6)(118.3)(176.5)(124.9)(154.7)(831.1)(35.9)(142.7)(94.8)(42.3)(75.4)149.6188.6541.8
% effective tax rate
21.9
(29.5%)
23.1
(81.1%)
0.7
(4.8%)
2.6
7.8%
1.1
186.2%
(227.3)
1,057.7%
10.2
(23.4%)
(3.9)
3.3%
(0.2)
0.1%
9.1
(7.3%)
17.1
(11.0%)
(200.8)
24.2%
81.2
(226.2%)
(65.5)
45.9%
(71.0)
74.8%
(901.4)
2,129.9%
(11.3)
15.0%
8.0
5.4%
20.9
11.1%
114.9
21.2%
% margin
(74.3)
(289.3%)
(28.5)
(33.9%)
(15.8)
(13.0%)
30.8
10.4%
(0.5)
(0.2%)
205.8
54.7%
(53.8)
(12.2%)
(114.3)
(22.8%)
(176.4)
(32.2%)
(134.0)
(17.8%)
(171.8)
(19.3%)
(630.2)
(56.4%)
(117.0)
(8.9%)
(77.2)
(5.2%)
(23.8)
(1.4%)
854.0
45.9%
(64.1)
(3.5%)
141.6
6.8%
167.6
6.9%
426.9
15.0%
EPS(1.08)(0.34)(0.16)0.31(0.00)1.99(0.48)(0.95)(1.28)(0.92)(1.07)(3.80)(0.67)(0.44)(0.13)4.75(0.35)0.760.892.13
Diluted EPS(1.08)(0.34)(0.16)0.29(0.00)1.73(0.48)(0.95)(1.28)(0.92)(1.07)(3.79)(0.67)(0.44)(0.13)4.53(0.35)0.750.872.06
% margin
(54.5)
(212.2%)
(14.9)
(17.7%)
(57.3)
(47.1%)
67.4
22.7%
35.6
11.0%
17.1
4.5%
(0.2)
(0.0%)
(79.8)
(15.9%)
(137.4)
(25.0%)
(50.0)
(6.7%)
(110.7)
(12.4%)
(705.5)
(63.2%)
94.8
7.2%
(3.5)
(0.2%)
33.9
2.0%
(5.9)
(0.3%)
48.0
2.6%
267.5
12.8%
310.3
12.8%
650.5
22.8%

Discover more Stock Ideas

FAQ

1) What is BioMarin Pharmaceutical Inc.'s Return on Invested Capital (ROIC)?

As of today, Microsoft Corp's last 12-month Return on Invested Capital (ROIC) is 11.0%, based on the financial report for Dec 31, 2024 (Q4’2024). The average annual Return on Invested Capital (ROIC) for BioMarin Pharmaceutical Inc. have been 4.8% over the past three years, and 8.9% over the past five years.

2) Is BioMarin Pharmaceutical Inc.'s Return on Invested Capital (ROIC) Good?

As of today, BioMarin Pharmaceutical Inc.'s Return on Invested Capital (ROIC) is 11.0%, which is higher than industry median of (139.1%). It indicates that BioMarin Pharmaceutical Inc.'s Return on Invested Capital (ROIC) is Good.

3) How does BioMarin Pharmaceutical Inc.'s Return on Invested Capital (ROIC) compare to its peers?

As of today, BioMarin Pharmaceutical Inc.'s Return on Invested Capital (ROIC) is 11.0%, which is higher than peer median of (13.8%). The list of peers includes UTHR, REGN, RPRX, ALNY, INCY, VRTX, BNTX, ARGX, BGNE, SMMT.